Join the editors of Genetic Engineering & Biotechnology News and an all-star line-up of speakers as we analyze the state of biotechnology – a celebration of innovation, emerging technologies, and clinical successes and an in-depth appraisal of the headwinds and challenges facing the industry.
On Wednesday, September 21th, 2022, our CEO Colin Hill, will be on a panel discussion entitled “The State of AI in Biotech“. He will be joined by Daphne Koller, CEO Insitro, and Andrew Hopkins, CEO Exscientia. The session will be moderated by Jonathan Grinstein, GEN Edge editor.
Save your virtual seat for an insightful panel discussion and register for a free ticket here: http://ow.ly/LUiJ50Kcmkv